Science News Roundup: Space startup partners with SpaceX to launch commercial space station; Human genome reboot better reflects global population and more

Following is a summary of current science news briefs. Space startup partners with SpaceX to launch commercial space station Vast, a startup backed by cryptocurrency billionaire Jed McCaleb, is aiming to launch a school bus-sized space station to orbit by late 2025 with some help from partner SpaceX, Elon Musk's rocket firm.

Following is a summary of current science news briefs.

Space startup partners with SpaceX to launch commercial space station

Vast, a startup backed by cryptocurrency billionaire Jed McCaleb, is aiming to launch a school bus-sized space station to orbit by late 2025 with some help from partner SpaceX, Elon Musk's rocket firm. The cylindrical spacecraft dubbed Haven-1 is the latest platform planned as a replacement to the International Space Station, a two-decade-old orbital research laboratory run primarily by the U.S., Russia and the European Space Agency.

Human genome reboot better reflects global population

Scientists on Wednesday unveiled a new accounting of the human genome that improves on its predecessor by including a rich diversity of people to better reflect the global population - a boost to ongoing efforts to identify genetic underpinnings of diseases and new ways to treat them. This "pangenome" achievement was announced two decades after the first sequencing of the human genome, a feat that transformed biomedical research by giving scientists a reference map to analyze DNA for clues about disease-related mutations.

Argentina's Bioceres to expand GMO wheat sales via seed marketers

Argentine biotech firm Bioceres will expand sales of its HB4 wheat seeds, which harness the power of genetically-modified organisms (GMO), to dozens of seed companies to boost future sales of the drought-tolerant product, Bioceres said on Thursday. The announcement to partner with additional seed multipliers, companies that sell seeds to farmers but do not develop new varieties themselves, marks an advance for the adoption of Bioceres' proprietary HB4 wheat.